MARAVAI LIFESCIENCES HOLDINGS, INC. 8-K

What Happened

• Maravai LifeSciences Holdings, Inc. (MRVI) announced its financial results for the first quarter of 2026 by issuing a press release on May 7, 2026. The company furnished the full press release as Exhibit 99.1 to its Form 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date of announcement: May 7, 2026.
• Filing: Current Report on Form 8-K, Item 2.02; press release furnished as Exhibit 99.1.
• Exhibit note: Exhibit 99.1 is “furnished,” not “filed,” and therefore is not subject to Section 18 liability or automatically incorporated by reference into other filings.
• Form signed by: Rajesh Asarpota, Chief Financial Officer, on behalf of the company.

Why It Matters

• This 8-K signals that Maravai has released its quarterly earnings and related operating results for Q1 2026—key information investors use to evaluate recent revenue, earnings trends, and company performance.
• Because the press release is furnished (not filed), investors should review the Exhibit 99.1 press release for the specific revenue, profit/loss, and operational details, and watch for the company’s subsequent 10-Q for the formal, detailed financial statements and disclosures.